National Academies Press: OpenBook

Vaccines Against Malaria (1996)

Chapter: Appendix: Workshop Agenda

« Previous: References
Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×

Appendix

Workshop Agenda

INSTITUTE OF MEDICINE

National Academy of Sciences

Board on International Health

Board on Health Promotion and Disease Prevention

Workshop on Malaria Vaccines

19–20 October 1995

Cecil and Ida Green Building, Room 104

2001 Wisconsin Avenue, N.W.

Washington, DC 20007

(202) 334-3904

AGENDA

19 October 1995

8:30 a.m.–8:45 a.m.

Welcome and Introductions

 

Philip Russell, Chair, IOM Committee on Malaria Vaccines

8:45 a.m.–10:45 a.m.

SESSION I: SETTING THE STAGE

(8:45 a.m.–9:15 a.m.)

Malaria: The Deteriorating Situation

 

Donald Krogstad, Tulane University School of Public Health and Tropical Medicine, USA

(9:15 a.m.–9:45 a.m.)

The Promise of Malaria Vaccines

 

Jerald Sadoff, Merck Research Laboratories, USA

Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×

(9:45 a.m.–10:05 a.m.)

Malaria Vaccines in the Field: A Perspective from the Africa Malaria Vaccine Testing Network

 

Wenceslaus Kilama, The African Malaria Vaccine Testing Network, Tanzania

(10:05 a.m.–10:30 a.m.)

Discussion

 

Moderator: Philip Russell

10:30 a.m.–11:00 a.m.

Break

11:00 a.m.–12:00 p.m.

SESSION II: MALARIA AS A PARADIGM

 

Stephen Hoffman, Naval Medical Research Institute, USA

(11:40 a.m.–12:00 p.m.)

Discussion

 

Moderator: Louis Miller, National Institutes of Health, USA

12:00 p.m.–1:00 p.m.

Lunch

1:00 p.m.–3:30 p.m.

SESSION III: CURRENT APPROACHES TO MALARIA VACCINE DEVELOPMENT

(1:00 p.m.–1:25 p.m.)

Preerythrocytic Vaccines

 

Ruth Nussenzweig, New York University Medical Center, USA

(5 min.)

Questions

(1:30 p.m.–1:55 p.m.)

Erythrocytic Vaccines

 

Graham Brown, The Walter and Eliza Hall Institute of Medical Research, Australia

(5 min.)

Questions

(2:00 p.m.–2:25 p.m.)

Transmission Blocking Vaccines

 

David Kaslow, National Institutes of Health, USA

(5 min.)

Questions

(2:30 p.m.–3:30 p.m.)

Discussion: Potential Immunologic Obstacles toDevelopment of an Optimal Multi-Immune Response, Multi-Stage Malaria Vaccine

 

Moderator: W. R. Ballou, Walter Reed Army Institute of Research, USA

3:30 p.m.–4:00 p.m.

Break

Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×

4:00 p.m.–5:30 p.m.

SESSION IV: ROUNDTABLE ON U.S. FEDERAL MALARIA VACCINE ACTIVITIES

Summary of Agency Activities
20 October 1995

(4:00 p.m.–4:15 p.m.)

Public Health Service

 

Daniel Colley, Centers for Disease Control and Prevention

(4:15 p.m.–4:30 p.m.)

Department of Defense

 

William Bancroft, U.S. Army Medical Research and Materiel Command

(4:30 p.m.–4:45 p.m.)

U.S. Agency for InternationalDevelopment

 

Carter Diggs, USAID

(4:45 p.m.–5:00 p.m.)

Federal Malaria Vaccine Coordinating Committee

 

Lee Hall, National Institutes of Health

(5:00 p.m.–5:30 p.m.)

Roundtable Discussion

 

Moderator: Lee Hall

5:30 p.m.

Reception (North Prefunction Area, directly outside meeting room)

8:30 a.m.–10:15 a.m.

SESSION V: ROUNDTABLE ON INDUSTRIAL SECTOR ACTIVITIES

(8:30 a.m.–9:00 a.m.)

Malaria Vaccine Development: A Perspective from Industry

 

Russell Howard, Glaxo-Wellcome

(9:00 a.m.–9:35 a.m.)

The following participants may wish to present for 5 min. each:

 

Ian Bathurst, LXR Biotechnology

W. Neal Burnette, Molecular Pharmaceutics Corporation

Kenneth Guito, Connaught Laboratories

Maurice Hilleman, The Merck Institute

Adeoye Olukotun, Bristol-Myers Squibb Company

John Tine, Virogenetics Corporation

Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×

(9:35 a.m.–10:15 a.m.)

Roundtable Discussion

Moderator: Russell Howard

10:15 a.m.–10:45 a.m.

Break

10:45 a.m.–12:15 a.m.

SESSION VI: ROUNDTABLE ON INTERNATIONAL COLLABORATION

(10:45 a.m.–11:00 a.m.)

Overview of Global Malaria Vaccine Activities

Howard Engers, WHO Special Programme for Research and Training in Tropical Diseases, Switzerland

(11:00 a.m.–11:15 a.m.)

DANIDA and Commission of European Communities

Palle Jakobsen, Denmark

(11:15 a.m.–11:25 a.m.)

African Malaria Vaccine Testing Network

Wenceslaus Kilama, Tanzania

(11:25 a.m.–11:35 a.m.)

Walter and Eliza Hall Institute of Medical Research

Graham Brown, Australia

(11:35 a.m.–11:45 a.m.)

Medical Research Council

Michael Davies, Great Britain

(11:45 a.m.–12:15 p.m.)

Roundtable Discussion

Moderator: Howard Engers (session will include participants from the Roundtable on U.S. Federal Malaria Vaccine Activities)

12:15 p.m.–1:00 p.m.

SESSION VII: SUMMARY AND DISCUSSION OF FINDINGS, CONCLUSIONS, AND RECOMMENDATIONS

Philip Russell, IOM Committee Chair

1:00 p.m.

Workshop Adjournment

1:30 p.m.–5:00 p.m.

EXECUTIVE SESSION

Workshop Committee on Malaria Vaccines

Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×
Page 27
Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×
Page 28
Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×
Page 29
Suggested Citation:"Appendix: Workshop Agenda." Institute of Medicine. 1996. Vaccines Against Malaria. Washington, DC: The National Academies Press. doi: 10.17226/9027.
×
Page 30
Vaccines Against Malaria Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!